Skip to main content

OXURION : Publication Annual Report - Annual Shareholders Meeting

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Leuven, BELGIUM – April 30, 2026 – 18:30 PM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, has today published its annual report for the financial year 2025. The annual report for the year ending December 31, 2025 is available in the “Investors” section of the Company's website and can also be downloaded as a PDF.

On this day as well, the Company has convened its Annual Shareholders' Meeting. The relevant documents pertaining to this Meeting have been published in the section “Shareholders Meetings”.

About Oxurion

Oxurion NV (Euronext Brussels: OXUR) is a company specializing in acquiring majority stakes in promising European pharmaceutical subcontractors. Oxurion's ambition is to build an integrated group of subcontractors serving healthcare players. The Group's headquarters are based in Leuven, Belgium. More information is available at www.oxurion.com.

Important information about forward-looking statements

Certain statements in this press release may be considered “forward-looking”. Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws.

Additional Disclaimer

The planned investment in digital assets (such as Bitcoin and Ethereum) exposes the company to specific risks related to volatility, regulatory uncertainty, and cybersecurity. These factors may significantly affect the expected performance of the investments.

For further information please contact:

Oxurion NV
Pascal Ghoson,
Chief Executive Officer
Pascal.ghoson@oxurion.com


This publication embed "🔒 Actusnews SECURITY MASTER".
- SECURITY MASTER Key: xWduZ5pnZW/KyGqcaZttbmNrm22UmpHHmZPHmWWcmJ6XmZ9nlZpnmpjIZnJplWVv
- Check this key: https://www.security-master-key.com.



Regulated information:
News releases for the provision of documents:
- Terms of availability of the preparatory documents for the GM


Full and original press release in PDF: https://www.actusnews.com/news/98009-oxur-shareholders-meeting-en-20260430.pdf

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  265.06
+2.02 (0.77%)
AAPL  271.35
+1.18 (0.44%)
AMD  354.49
+17.38 (5.16%)
BAC  53.46
+0.58 (1.10%)
GOOG  381.94
+34.63 (9.97%)
META  611.91
-57.21 (-8.55%)
MSFT  407.78
-16.68 (-3.93%)
NVDA  199.57
-9.68 (-4.63%)
ORCL  161.39
-2.44 (-1.49%)
TSLA  381.63
+8.83 (2.37%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.